American Society of Hirudotherapy

Recurrent Otitis Media in Adults (Investigational)

Highly investigational adjunct for adult recurrent otitis media; no condition-specific study found; antibiotics and ENT evaluation remain primary.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 12, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for recurrent otitis media. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use for recurrent adult otitis media is investigational.
What evidence exists?
Tier C (investigational). No study of leech therapy specifically for recurrent otitis media in adults was identified; small uncontrolled reports exist for other forms of otitis, and there are no randomized controlled trials. Evidence-based management of recurrent adult otitis media: ENT evaluation to identify underlying eustachian tube dysfunction, allergic rhinitis, nasopharyngeal pathology, or immune deficiency; treatment of underlying allergic rhinitis with intranasal corticosteroids; antibiotic therapy for acute episodes; tympanostomy tube placement in selected cases; rare adult mastoidectomy.
Main risks
  • Bleeding from bite sites for 6 to 24 hours after detachment
  • Worsening of ear pain or middle ear effusion
  • Local skin infection or, rarely, Aeromonas infection near the ear
  • Allergic reaction to leech saliva (uncommon)
  • Risk if leech placed too close to the external auditory canal or facial nerve
  • Trigger of acute otitis externa from leech saliva or bleeding into canal
  • Permanent small scars at bite sites near the ear
  • Delay of ENT evaluation for underlying cause or surgical management
Who should not consider this
  • Patients with acute purulent otitis media (treat with antibiotics first)
  • Patients with suspected mastoiditis or intracranial complications (emergency)
  • Patients with tympanic membrane perforation
  • Patients with hearing loss requiring audiology evaluation
  • Patients on anticoagulants, with hemophilia, or with anemia
  • Patients who have not had an ENT evaluation for underlying cause
What to ask your clinician
  • Have I been evaluated by an ENT specialist for underlying cause?
  • Has nasopharyngeal pathology, allergic rhinitis, or immune deficiency been ruled out?
  • Am I a candidate for tympanostomy tube placement?
  • Have I had a tympanogram and audiogram to assess middle ear function?
  • What evidence specifically supports leech therapy for recurrent otitis media?
  • What is the practitioner's experience with leech placement near the ear?
  • What is the cost and is it covered by insurance? (typically not covered)
When to seek urgent care
  • Severe ear pain with high fever (possible mastoiditis)
  • Facial weakness or asymmetry (facial nerve involvement)
  • Severe headache, neck stiffness, or confusion (possible intracranial complication)
  • Sudden hearing loss
  • Spreading redness, warmth, pus behind the ear (mastoiditis)
  • Fever above 38.0 C / 100.4 F or chills
  • Bleeding from a bite site lasting more than 24 hours
  • Hives, facial or tongue swelling, throat tightness, or breathing difficulty

What this does NOT mean

  • This is NOT FDA-cleared for recurrent otitis media.
  • The small uncontrolled reports in other forms of otitis do NOT establish efficacy versus ENT evaluation, intranasal corticosteroids, antibiotics, or tympanostomy tubes.
  • It does NOT address underlying eustachian tube dysfunction, allergic rhinitis, or immune deficiency.
  • It does NOT substitute for audiology and tympanometry evaluation.
  • It does NOT mean leech application is safe near the ear — superinfection and facial nerve risk are real.

Clinical Profile

Category
ENT
ICD-10
H66.001, H66.91, H66.92
Safety tier
High

Evidence Summary

Recurrent otitis media in adults is uncommon and warrants ENT evaluation for nasopharyngeal pathology, eustachian tube dysfunction, immunodeficiency, or anatomic abnormality. Management per AAO-HNS includes antibiotics for acute episodes, eustachian tube balloon dilation for chronic dysfunction, and tympanostomy tubes in selected cases. No study of leech therapy specific to recurrent otitis media in adults was identified in PubMed, Europe PMC, Crossref or Russian-language sources, so its use for this condition is investigational. The nearest clinical reports concern other forms of otitis and are small or non-randomized: Seleznev 1992 treated tinnitus, acute external otitis and chronic otitis media with leeches or diluted leech saliva (273 patients across all diagnoses, per Baskova and Isakhanyan 2004), a 2025 uncontrolled Azerbaijan series reported improvement in 3 of 5 patients with otitis media (Farzali 2025), and a Russian dissertation reported better outcomes with combined therapy including leeches than with conventional therapy in children with exudative otitis media (Kuzmina 2006). None of these addresses recurrent otitis media in adults, and none is described as randomized or blinded. The underlying eustachian tube and nasopharyngeal contributors are not addressed by peripheral leech application, and bacterial etiologies require antibiotic therapy. Evidence is grade D.

What the books describe

Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.

  • Baskova and Isakhanyan do not write directly about recurrent otitis media: in their list of indications they name otitis media in general — acute (without perforation of the eardrum), chronic and adhesive[B1].
  • Baskova and Isakhanyan describe a study by Seleznev and co-authors (1992) in 273 patients with acute otitis externa, chronic otitis media and ear noise (tinnitus): in some, leech saliva was introduced into the skin by microelectrophoresis, in others ordinary hirudotherapy sessions were carried out, and in the third group ordinary drug treatment was used; in this description the results are not separated by diagnosis, so it does not show what exactly happened in patients with otitis media[B1].
  • On chronic otitis media in older people, Baskova and Isakhanyan cite an observation by Grigoryev, Krymskaya and Krymskaya (1998): in such patients, by their description, neurological symptoms of vascular origin were found that outwardly resembled intracranial complications of otitis, together with changes in the blood (high cholesterol, fibrinogen and prothrombin index, a shortened clotting time); these changes, it is said, could be corrected with leeches; the number of patients and a comparison group are not given[B1].
  • Flecken and Michalsen (chapter 5) write that the practice of leeching to treat otitis and otitis media is especially widespread in Eastern Europe and is partially backed up by study data[B3].
  • Michalsen, in chapter 10, describing the study by Baskova’s team (273 patients with otitis media or otitis externa or tinnitus, three groups), writes that hirudotherapy showed significant superiority in alleviating the symptoms of otitis externa and tinnitus but had no demonstrable effect in otitis media; he qualifies this by saying that the results should be interpreted with caution, especially for tinnitus[B3].
  • Baskova and Isakhanyan advise refraining from hirudotherapy at high body temperature, while Flecken and Michalsen write that in the acute stage of infectious diseases it may, according to experience, cause weakness and impair wound healing[B1][B3].
  • Among the contraindications, Baskova and Isakhanyan, like Flecken and Michalsen in chapter 8 of the book by Michalsen et al., name hemophilia, anemia and concurrent use of anticoagulants (drugs that reduce blood clotting)[B1][B3].

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Active otitis media (treat with antibiotics first)
  • Cholesteatoma or tympanic membrane perforation
  • Recent ear surgery or tympanostomy
  • Pediatric patient (no evidence in children)
  • Any intra-aural placement

Related Conditions

References

  • [B1]

    Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]

    Москва: Монолит(2004)https://search.rsl.ru/ru/record/01007959553

    Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.

  • [B3]

    Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy

    Stuttgart — New York: Thieme(2007)https://books.google.com/books?vid=ISBN9781588905635

    ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.

The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.